These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24638211)

  • 21. Filter Size Not the Anticoagulation Method is the Decisive Factor in Continuous Renal Replacement Therapy Circuit Survival.
    Miklaszewska M; Korohoda P; Zachwieja K; Kobylarz K; Stefanidis CJ; Sobczak A; Drożdż D
    Kidney Blood Press Res; 2017; 42(2):327-337. PubMed ID: 28578343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
    Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using additional pressure control lines when connecting a continuous renal replacement therapy device to an extracorporeal membrane oxygenation circuit.
    Na SJ; Choi HJ; Chung CR; Cho YH; Jang HR; Suh GY; Jeon K
    BMC Nephrol; 2018 Dec; 19(1):369. PubMed ID: 30567509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of a program designed to improve continuous renal replacement therapy stability].
    Page M; Rimmelé T; Prothet J; Christin F; Crozon J; Ber CE
    Ann Fr Anesth Reanim; 2014 Dec; 33(12):626-30. PubMed ID: 25458458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Combined Extracorporeal Life Support and Continuous Renal Replacement Therapy on Hemodynamic Performance and Gaseous Microemboli Handling Ability in a Simulated Neonatal ECLS System.
    Shank KR; Profeta E; Wang S; O'Connor C; Kunselman AR; Woitas K; Myers JL; Ündar A
    Artif Organs; 2018 Apr; 42(4):365-376. PubMed ID: 28940550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of connecting continuous renal replacement therapy to the extracorporeal membrane oxygenation circuit.
    de Tymowski C; Desmard M; Lortat-Jacob B; Pellenc Q; Alkhoder S; Alouache A; Fritz B; Montravers P; Augustin P
    Anaesth Crit Care Pain Med; 2018 Dec; 37(6):557-564. PubMed ID: 29572101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement.
    Broman M; Klarin B; Sandin K; Carlsson O; Wieslander A; Sternby J; Godaly G
    ASAIO J; 2015; 61(4):437-42. PubMed ID: 25851312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    Rodriguez K; Srivaths PR; Tal L; Watson MN; Riley AA; Himes RW; Desai MS; Braun MC; Akcan Arikan A
    PLoS One; 2017; 12(8):e0182134. PubMed ID: 28792509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
    Stucker F; Ponte B; Tataw J; Martin PY; Wozniak H; Pugin J; Saudan P
    Crit Care; 2015 Mar; 19(1):91. PubMed ID: 25881975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation for continuous renal replacement therapy.
    Tolwani AJ; Wille KM
    Semin Dial; 2009; 22(2):141-5. PubMed ID: 19426417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy.
    Zhang Z; Hongying N
    Intensive Care Med; 2012 Jan; 38(1):20-8. PubMed ID: 22124775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal replacement therapy and anticoagulation.
    Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Hemodynamic Performance of a Combined ECLS and CRRT Circuit in Seven Positions With a Simulated Neonatal Patient.
    Profeta E; Shank K; Wang S; O'Connor C; Kunselman AR; Woitas K; Myers JL; Ündar A
    Artif Organs; 2018 Feb; 42(2):155-165. PubMed ID: 28621839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].
    Zhang C; Lin T; Zhang J; Liang H; Di Y; Li N; Gao J; Wang W; Liu S; Wang Z; Jiang H; Liu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Aug; 30(8):777-782. PubMed ID: 30220281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citrate anticoagulation in a piglet model of pediatric continuous renal replacement therapy.
    Nuthall G; Skippen P; Daoust C; Al-Jofan F; Seear M
    Crit Care Med; 2002 Apr; 30(4):900-3. PubMed ID: 11940766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial.
    Ramesh Prasad GV; Palevsky PM; Burr R; Lesko JM; Gupta B; Greenberg A
    Clin Nephrol; 2000 Jan; 53(1):55-60. PubMed ID: 10661483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction.
    Klingele M; Stadler T; Fliser D; Speer T; Groesdonk HV; Raddatz A
    Crit Care; 2017 Nov; 21(1):294. PubMed ID: 29187232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of Vascular Access and Anticoagulation.
    Honore PM; Spapen HD
    Contrib Nephrol; 2018; 194():15-24. PubMed ID: 29597215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.